A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.

A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab. Inflamm Bowel Dis. 2022 10 03; 28(10):1549-1554.

View in: PubMed

subject areas

Antibodies, Monoclonal, Humanized
Colitis, Ulcerative
C-Reactive Protein
Cyclosporine
Follow-Up Studies
Gastrointestinal Agents
Humans
Induction Chemotherapy
Leukocyte L1 Antigen Complex
Prospective Studies
Remission Induction
Steroids
Treatment Outcome

authors with profiles

David T. Rubin